π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
This experiment will test the safety and effectiveness of a treatment for m...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1999-08
Trial ID
NCT00001832
Background: * The National Cancer Institute (NCI) Surgery Branch has devel...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-12-12
Trial ID
NCT01993719
This prospective, single-center pilot study is being performed to find out ...
Status
Not Yet Recruiting
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2026-10-01
Trial ID
NCT07700121
The purpose of this Pilot Study is to investigate the safety, side effects,...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2016-03-08
Trial ID
NCT02652455
Background: Cell therapy is an experimental cancer therapy. It takes young...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2015-12-04
Trial ID
NCT02621021
Treatments Being Tested
To determine the feasibility and safety of administering a regimen of TIL/I...
Status
Terminated
Location
Yale New Haven Hospital
Start Date
2018-02-06
Trial ID
NCT03526185
Treatments Being Tested
Phase 1b open-label study to evaluate the safety of selected TIL (TBio-4101...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2024-03-14
Trial ID
NCT06236425
Treatments Being Tested
Background: The presence of T-lymphocytes in resected tumor samples derive...
Status
Recruiting
Location
Vall d'Hebron Institute of Oncology
Start Date
2025-01-15
Trial ID
NCT06630611
This is a phase I/II clinical trial of a single dose of CD40L-augmented TIL...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2025-12-03
Trial ID
NCT06961357
Treatments Being Tested